MetLife Investment Management’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24,404
| Closed | -$38.8K | – | 2793 |
|
|
2024
Q4 | $38.8K | Buy |
24,404
+9,148
| +60% | +$14.5K | ﹤0.01% | 2758 |
|
|
2024
Q3 | $29.9K | Sell |
15,256
-33,503
| -69% | -$65.7K | ﹤0.01% | 2802 |
|
|
2024
Q2 | $80K | Buy |
48,759
+8,069
| +20% | +$13.2K | ﹤0.01% | 2682 |
|
|
2024
Q1 | $209K | Hold |
40,690
| – | – | ﹤0.01% | 2182 |
|
|
2023
Q4 | $233K | Hold |
40,690
| – | – | ﹤0.01% | 2156 |
|
|
2023
Q3 | $194K | Buy |
40,690
+9,687
| +31% | +$46.3K | ﹤0.01% | 2227 |
|
|
2023
Q2 | $132K | Hold |
31,003
| – | – | ﹤0.01% | 2522 |
|
|
2023
Q1 | $165K | Hold |
31,003
| – | – | ﹤0.01% | 2339 |
|
|
2022
Q4 | $195K | Hold |
31,003
| – | – | ﹤0.01% | 2257 |
|
|
2022
Q3 | $327K | Hold |
31,003
| – | – | ﹤0.01% | 1937 |
|
|
2022
Q2 | $168K | Hold |
31,003
| – | – | ﹤0.01% | 2433 |
|
|
2022
Q1 | $285K | Buy |
31,003
+23,472
| +312% | +$215K | ﹤0.01% | 2124 |
|
|
2021
Q4 | $114K | Hold |
7,531
| – | – | ﹤0.01% | 2365 |
|
|
2021
Q3 | $180K | Buy |
+7,531
| New | +$180K | ﹤0.01% | 2164 |
|